News

Jade Biosciences Gears Up for Key Conference Appearances

Jade Biosciences Gears Up for Key Conference Appearances

Jade Biosciences Gears Up for Key Conference Appearances

Jade Biosciences, Inc., a pioneering biotechnology firm focused on cutting-edge therapies for autoimmune diseases, is preparing to showcase its latest developments at several significant upcoming conferences. The company, listed on Nasdaq under the ticker JBIO, is committed to addressing pressing needs in autoimmune treatment.

Scheduled Conferences

This November, Jade will participate in a series of prominent healthcare gatherings designed to highlight advancements in the biotechnology field:

Wedbush Rewind ASN Conference 2025

The first stop for Jade will be the Wedbush Rewind ASN Conference. Here, the company plans to engage in a fireside chat on November 10, discussing the implications of their lead therapies and their vision for the future.

Stifel Healthcare Conference

Following quickly on the heels of the ASN Conference, Jade will feature at the Stifel Healthcare Conference from November 11-13. A key presentation is slated for November 12 at 4:00 p.m. ET, where Jade will share insights into its current projects and future innovations.

TD Cowen Immunology & Inflammation Virtual Summit

From November 12-13, the TD Cowen Summit will showcase groundbreaking work in immunology, including Jade's presentations. On November 13, at 3:00 p.m. ET, the company aims to impress attendees with its unique approach to tackling inflammation-related diseases.

Jefferies Global Healthcare Conference

Rounding off the month, Jade will participate in the Jefferies Global Healthcare Conference taking place from November 18-20. The company is eager to engage with healthcare leaders and industry experts during its presentation on November 17 at 3:30 p.m. GMT.

How to Access Webcasts

For those not attending in person, Jade Biosciences will provide live webcasts of all presentations on its official website. Each event will also feature a replay accessible for 90 days, ensuring all interested parties can benefit from the insights shared.

About Jade Biosciences

Founded with a mission to develop best-in-class therapies, Jade Biosciences is invested in redefining treatment approaches for autoimmune diseases. The company’s leading candidate, JADE101, is currently in a Phase 1 clinical trial aimed at treating immunoglobulin A nephropathy. Furthermore, its strong pipeline includes the innovative JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and the undisclosed JADE-003 antibody discovery program, both in preclinical stages.

Company Contact Information

For media inquiries or to learn more, please reach out to Priyanka Shah at Media@JadeBiosciences.com or for investor relations, contact IR@JadeBiosciences.com. Interested parties can also reach Jade at 908-447-6134.

Frequently Asked Questions

What is the main focus of Jade Biosciences?

Jade Biosciences focuses on developing therapies for autoimmune diseases, seeking to address unmet medical needs in this area.

What upcoming events will Jade Biosciences participate in?

Jade will participate in key conferences including the Wedbush Rewind ASN Conference and the Jefferies Global Healthcare Conference, among others.

How can I access Jade Biosciences' presentations?

All presentations will be streamed live on Jade's official website, with replays available afterwards for 90 days.

What is the lead candidate of Jade Biosciences?

JADE101, which targets the cytokine APRIL, is the lead candidate and is currently in a Phase 1 clinical trial for treatment of immunoglobulin A nephropathy.

How can I contact Jade Biosciences for more information?

You can contact Jade Biosciences through their media or investor relations emails: Media@JadeBiosciences.com or IR@JadeBiosciences.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 1

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 2

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 2

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 3

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 3

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 1

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 2

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 2

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

John B. Sanfilippo & Son Announces Major $1.00 Special Dividend

Updated Category News Views 156

John B. Sanfilippo & Son Declares Special $1.00 Dividend The management of John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) has exciting news for its shareholders as the company has declared a special cash dividend of $1.00 per share. This amount will be distributed on shares of both Common Stock and Class A Common Stock, which is expected to return about $11.7 million to...

Continue Reading
Recent Disclosure Submission by De La Rue plc Explained

Updated Category News Views 262

Understanding Recent Disclosure Submissions Corporations frequently engage in the process of disclosing financial information to ensure transparency and compliance with market regulations. Among these, De La Rue plc, a prominent player in the printing and security technology sector, has made an important disclosure pertaining to trades conducted by its exempt principal...

Continue Reading
Perrigo Company Engages Investors at Upcoming Conference

Updated Category News Views 114

Perrigo Company Engages Investors at Upcoming Conference Dublin - Perrigo Company plc (NYSE: PRGO), renowned for its commitment to consumer health products, has announced that its President and CEO, Patrick Lockwood-Taylor, along with CFO Eduardo Bezerra, will participate in one-on-one investor meetings at the Jefferies Miami Consumer Conference. This event is set to...

Continue Reading
Hellas Verona Partners with Veronafiere for Chicago Event

Updated Category News Views 281

Hellas Verona and Veronafiere Collaborate for Vinitaly.USA Hellas Verona Football Club and Veronafiere are excited to announce their latest partnership, aimed at promoting the finest of Italian wines on an international platform. This collaboration emphasizes the upcoming second edition of Vinitaly.USA, a prestigious event highlighting Italian wine in the United States,...

Continue Reading
Bio-Techne to Showcase Innovations at Annual Healthcare Event

Updated Category News Views 159

Bio-Techne Corporation to Present at Key Healthcare Conference Bio-Techne Corporation (NASDAQ: TECH) is set to take the stage at a prestigious annual healthcare conference. With a focus on innovation and providing indispensable tools for the medical and research communities, Bio-Techne's President and CEO, Kim Kelderman, will share insights on January 14, 2025. This event...

Continue Reading